Concepedia

Ravi Rajagopalan

RR

5

Publications

310

Citations

5

H-Index

1995

Active since

Affiliations

Gilead Sciences (United States)(Current)

Theravance Biopharma (United States)

The University of Texas at Austin

Crown Bioscience (China)

Ravi Rajagopalan is an author at Gilead Sciences (United States) specializing in drug discovery, drug resistance, and medicine.

Top concepts

Publications per year

1995–2011

5

Publications

5

Effect of Quaternization of the Glucose Oxidase “Wiring” Redox Polymer on the Maximum Current Densities of Glucose Electrodes

Ravi Rajagopalan, Atsushi Aoki, Adam Heller · The Journal of Physical Chemistry · 1996 · 104 citations

Effect of quaternization on electron diffusion coefficients for redox hydrogels based on poly(4-vinylpyridine)

Atsushi Aoki, Ravi Rajagopalan, Adam Heller · The Journal of Physical Chemistry · 1995 · 91 citations

, , +15

Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior

Ravi Rajagopalan, Shawn Misialek, Sarah Stevens et al. · Biochemistry · 2009 · 59 citations

Quinolones as HCV NS5B polymerase inhibitors

Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 39 citations

, , +5

3-Heterocyclyl quinolone inhibitors of the HCV NS5B polymerase

Dange V. Kumar, Roopa Rai, Ken A. Brameld et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 17 citations

, , +6

Rows per page

1–5 of 5